We are live on ! Find out more
RCM

Rotella Capital Management Portfolio holdings

AUM $1.47M
1-Year Est. Return 12.32%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
-12.32%
3 Year Est. Return
+26.58%
5 Year Est. Return
10 Year Est. Return
AUM
$115M
AUM Growth
+$20.1M
Cap. Flow
+$14.9M
Cap. Flow %
12.95%
Top 10 Hldgs %
25.43%
Holding
511
New
200
Increased
86
Reduced
69
Closed
149

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 12.17%
2 Technology 8.26%
3 Consumer Staples 6.36%
4 Healthcare 4.58%
5 Financials 4.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LINC icon
301
Lincoln Educational Services
LINC
$1.25B
$48K 0.04%
+17,300
New +$51.4K
SORL
302
DELISTED
SORL Auto Parts, Inc.
SORL
$48K 0.04%
13,011
+2,668
+26% +$10.2K
GALT icon
303
Galectin Therapeutics
GALT
$212M
$47K 0.04%
+13,505
New +$59.7K
LFVN icon
304
LifeVantage
LFVN
$83M
$47K 0.04%
5,188
+2,728
+111% +$25K
EROC
305
DELISTED
EAGLE ROCK ENERGY PARTNERS, L.P. COM UNITS RPTNG LTD PRTNR
EROC
$47K 0.04%
+21,489
New +$62.6K
ACHV icon
306
Achieve Life Sciences
ACHV
$672M
$45K 0.04%
+9
New +$44K
MEET
307
DELISTED
The Meet Group, Inc. Common Stock
MEET
$44K 0.04%
+28,900
New +$50.3K
INUV icon
308
Inuvo
INUV
$16.8M
$43K 0.04%
3,280
-1,180
-26% -$15.7K
LOCM
309
DELISTED
LOCAL CORP COM STK (DE)
LOCM
$42K 0.04%
39,972
-26,332
-40% -$41.2K
BXC icon
310
BlueLinx
BXC
$671M
$41K 0.04%
3,564
-1,316
-27% -$15.6K
GYRE icon
311
Gyre Therapeutics
GYRE
$714M
$41K 0.04%
+20
New +$38.5K
XCO
312
DELISTED
Exco Resources
XCO
$41K 0.04%
+1,260
New +$52.6K
ZIXI
313
DELISTED
Zix Corporation
ZIXI
$40K 0.03%
+11,045
New +$37.7K
TST
314
DELISTED
TheStreet, Inc.
TST
$40K 0.03%
1,685
-1,780
-51% -$40.1K
ENZN
315
DELISTED
ENZON PHARMACEUTICALS INC
ENZN
$40K 0.03%
36,964
-16,188
-30% -$17K
ATEC icon
316
Alphatec Holdings
ATEC
$1.42B
$38K 0.03%
2,228
-1,921
-46% -$32.7K
ALSK
317
DELISTED
Alaska Communications Systems
ALSK
$38K 0.03%
21,123
+10,633
+101% +$15.9K
MVIS icon
318
Microvision
MVIS
$76.1M
$37K 0.03%
+1,408
New +$37.5K
TURN
319
DELISTED
180 Degree Capital
TURN
$36K 0.03%
+4,061
New +$35.1K
CNVS icon
320
Cineverse
CNVS
$62.3M
$35K 0.03%
107
+27
+34% +$8.73K
ETRM
321
DELISTED
EnteroMedics Inc.
ETRM
$35K 0.03%
23
-2
-8% -$2.7K
INSG icon
322
Inseego
INSG
$87.1M
$34K 0.03%
+1,058
New +$32.5K
GSAT icon
323
Globalstar
GSAT
$10.7B
$33K 0.03%
+793
New +$30.4K
MNOV icon
324
MediciNova
MNOV
$66.9M
$33K 0.03%
+10,701
New +$36.3K
AXAS
325
DELISTED
Abraxas Petroleum Corp
AXAS
$31K 0.03%
530
-40
-7% -$2.94K

Similar funds

Rotella Capital Management's Q4 2014 Portfolio in Review

As of Q4 2014, Rotella Capital Management held 511 positions worth $115M, up 21% from $95.3M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rotella Capital Management deployed $14.9M of net new capital in Q4 2014, opening 200 new positions and adding to 86 existing holdings. Its largest new stake was BIO-REFERENCE LABS INC-NEW-: 55,212 shares worth $1.77M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 12% of assets, up from 8% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Vanguard Total Bond Market, an estimated $2.36M trimmed.

  • Rotella Capital Management's largest Q4 2014 buy was BIO-REFERENCE LABS INC-NEW-: 55,212 shares worth $1.77M.
  • Rotella Capital Management added most to Vanguard Dividend Appreciation ETF in Q4 2014, an estimated $2.32M increase.
  • Rotella Capital Management's biggest Q4 2014 reduction was Vanguard Total Bond Market, cutting an estimated $2.36M.
  • Rotella Capital Management fully exited FMC in Q4 2014, selling an estimated $1.93M.
  • Rotella Capital Management's ten largest holdings make up 25% of its $115M portfolio in Q4 2014.
  • Rotella Capital Management opened 200 new positions and closed 149 in Q4 2014.
  • Rotella Capital Management's portfolio value rose 21% quarter-over-quarter to $115M.

Based on Rotella Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.